Ramon S. S.
- Country
- Spain
- Department
- Servicio de Oncología Médica
Research Overview
- Evaluation of the Safety, Tolerability, and Efficacy of the Pan-KRAS Inhibitor LY4066434 in Patients with KRAS Mutant Advanced Solid Tumors
- Phase 1 Study of PF-07985045 in Patients with KRAS Mutated Advanced Solid Tumors
- Phase 1b Study of OMTX705 in Patients with Advanced/Metastatic Pancreatic Adenocarcinoma
Data & Insights
Has run more than one trial at 63 of 157 partner sites.
Specializations
Oncology Research
The investigator specializes in studying advanced solid tumors with a particular focus on cases involving KRAS mutations.
- Targeted Cancer Therapy
- KRAS Pathway Inhibition
- Advanced Solid Tumors
Key interest in novel therapeutic approaches for treating KRAS-mutated cancers.
Molecular Oncology
Focuses on the investigation of molecular pathways and their role in cancer development, particularly those involving KRAS signaling.
- Cancer Genetics
- Mutation Analysis
- Signal Transduction
Investigates innovative approaches in targeting specific molecular alterations in cancer.
Clinical Development
Engaged in evaluating novel therapeutic agents, with expertise in pan-KRAS inhibitors and their applications in treating advanced cancers.
- Drug Safety Assessment
- Therapeutic Efficacy
- Treatment Tolerability
Specialized in characterizing new treatment options for advanced cancer patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.